Contract manufacturer of biologics for immunodiagnostic, bio-pharmaceutical and environmental biotechnology applications. Contract RD; creation, development and optimisation of cell lines; process development and validation; production and purification of proteins (milligram to multi-gram quantities)to enable characterisation, pre-clinical testing, and scale-up for clinical trials.. Specialist in hybridoma technology and production/purification of monoclonal antibodies and recombinant proteins from mammalian cell lines. . . Development of bioassays for environmental monitoring. Microbial and monoclonal antibody-based bioassays for identifying pathogens and determining toxicity of wastewater and groundwater.. . Technologies: Hollowfibre bioreactors; spinner/roller culture; stirred vessel bioreactors; Affinity, ion-exchange and size exclusion chromatography.
BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers. Visit the BIO Member Directory to browse BIO members and Web site links as well as BIO state and international affiliates.. . Member services include: . * Federal and state advocacy on issues affecting the industry . * A dozen or more investor and partnering meetings throughout the year, with discounts for members . * Communications services that disseminate information about the benefits of biotechnology . * BIO Business Solutions discounts for a variety of goods and services . . Specific issues may have changed over the years, but our core mission of fostering biotechnology innovation through advocacy, business development and communications remains the same. . . BIO produces the annual BIO International Convention, the world's largest gathering of the biotechnology industry. The BIO International Convention attracts more than 20,000 attendees from around the world including more than 500 members of the international press. Convention attendees hear from global biotechnology leaders, learn about the latest biotech innovations and network with their peers from established and emerging biotech companies, research institutions, service providers and biotech hubs.. . BIO also produces a series of industry-leading investor and partnering meetings held around the world.
No data available
BOC Cryospeed is the UK and Ireland's most reliable and flexible supplier of mini-bulk liquid gases to support science. Cryospeed delivers liquid nitrogen, argon, oxygen and carbon dioxide. BOC is the UK’s largest supplier of speciality gases and equipment and has an unrivalled supply of gases and products to suit any application, plus many more that can be customised to match your requirements: Ecocyl, a unique portable package designed to meet requirements of low gas usage; a database of over 25000 individual gas product recipes. We can also customise products to your specification; gas control equipment.
Boult Wade Tennant is a specialist patent and trade mark firm. We exist to help individuals and businesses protect, manage and enforce intellectual property rights on a global scale. Our aim is simple – we aim to work with our clients, not just for them. This means that we place emphasis on the quality of our work and on the quality of the service we provide. Our award-winning approach is down-to-earth and jargon-free. Our attorneys are renowned for providing a service that is focused and aligned with our clients' commercial objectives. We are committed to helping our clients succeed.
Our experienced team provides consultancy services in relation to development of pharmaceutical and biotechnology products and medical devices: product R&D strategy, planning and execution; product manufacturer selection; pre-clinical study design and placement; clinical product development; regulatory strategy; clinical expert reports and overviews; scientific advice, orphan drug and paediatric plans; clinical trial applications; protocols and investigator’s brochures; MAA/NDA/BLA applications, lifecycle management; product commercialisation, clinical support activities; and due diligence evaluations. We are a cost-effective solution for those requiring assistance in order to expedite development and add value to your product, whether it relates to a single issue or a long term commitment.
Watch our Member Showcase video here https://bit.ly/3Gs0d87
Watch our Member Showcase video here https://bit.ly/3Gs0d87
Breakthrough Properties is a life science real estate investment firm that leverages cross-sector collaboration to deliver environments that foster innovation and scientific breakthroughs. Our team is a first-of-its-kind collaboration in real estate development, which came together through a shared passion that combines Tishman Speyer’s global real estate platform with Bellco Capital’s industry-making biotechnology entrepreneurship to capitalize on the rapidly expanding — yet substantially under-supplied — life science real estate industry. With real estate expertise spanning four continents, Tishman Speyer has built an international reputation for both developing and operating world-class properties across the globe. Bellco Capital is an industry-renowned investment firm that builds, invests in, and supports companies with bold ambitions of exponential transformation in life sciences. The Breakthrough team works hand-in-hand with both Tishman Speyer’s global real estate platform and Bellco’s extensive life science network to gain key insights and local support across the company’s core markets.
Bristows works with leading clients from across the sectors and offers a true spectrum of legal expertise, both contentious and non-contentious. The range of our experience enables us to advise on everything from the precedent-setting to the purely procedural. The common thread in everything we do is our ability to combine both commercial and legal perspectives. For more than 170 years, the Bristows name has represented a rigorous intellectual approach to the law, as well as a practical understanding of the ever-changing demands of business.
Broken String Bioscience’s technology platform, INDUCE-seq™ , supports the development of cell and gene therapies that are safer by design. INDUCE-seq™, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.
Bruntwood SciTech is the UK’s largest provider of office, lab and scientific services for the science and technology sector. Its network of innovation districts connects the UK’s most ambitious cities, regions and science and technology communities through collaboration and a unique public, private, academic, clinical partner network. Locations include Alderley Park, Citylabs, Liverpool Science Park and Manchester Science Park.
Watch our Member Showcase Video here https://bit.ly/3HZAfZX
Watch our Member Showcase Video here https://bit.ly/3HZAfZX